{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:11:18Z","timestamp":1791090678257,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":3211,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular &amp; Cellular Proteomics"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1074\/mcp.m111.011635","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T21:45:01Z","timestamp":1317246301000},"page":"M111.011635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Quantitative Chemical Proteomics Reveals New Potential Drug Targets in Head and Neck Cancer"],"prefix":"10.1016","volume":"10","author":[{"given":"Zhixiang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica B.","family":"Doondeea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin Moghaddas","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie C.","family":"Janning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Lemeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne A.","family":"Eccles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Gollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reidar","family":"Grenman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Walch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan M.","family":"Feller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Kuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.M111.011635_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/mcp.M111.011635_bib2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM199503163321104","article-title":"Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck","volume":"332","author":"Brennan","year":"1995","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/mcp.M111.011635_bib3","first-page":"509","article-title":"Analysis of PTEN\/MMAC1 alterations in aerodigestive tract tumors","volume":"58","author":"Okami","year":"1998","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib4","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/ijc.25474","article-title":"Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways","volume":"128","author":"Smeets","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1074\/mcp.M111.011635_bib5","first-page":"5997","article-title":"Frequent p53 mutations in head and neck cancer","volume":"52","author":"Somers","year":"1992","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib6","first-page":"4122","article-title":"A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains","volume":"61","author":"Redon","year":"2001","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib7","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1158\/0008-5472.CAN-08-3199","article-title":"Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma","volume":"69","author":"Sheu","year":"2009","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib8","first-page":"101","article-title":"Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas","volume":"32","author":"Murugan","year":"2008","journal-title":"Int. J. Oncol"},{"key":"10.1074\/mcp.M111.011635_bib9","first-page":"3408","article-title":"Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation","volume":"119","author":"Bornstein","year":"2009","journal-title":"J. Clin. Invest"},{"key":"10.1074\/mcp.M111.011635_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/path.1630","article-title":"Caspase-3 expression is reduced, in the absence of cleavage, in terminally differentiated normal oral epithelium but is increased in oral squamous cell carcinomas and correlates with tumour stage","volume":"204","author":"Hague","year":"2004","journal-title":"J. Pathol"},{"key":"10.1074\/mcp.M111.011635_bib11","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/carcin\/18.11.2285","article-title":"Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck","volume":"18","author":"Wang","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1074\/mcp.M111.011635_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1517\/14728222.2011.541440","article-title":"EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: Attractive targets for molecular-oriented therapy","volume":"15","author":"Freudlsperger","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1074\/mcp.M111.011635_bib13","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hed.21365","article-title":"Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck","volume":"32","author":"Sharafinski","year":"2010","journal-title":"Head Neck"},{"key":"10.1074\/mcp.M111.011635_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1748-717X-1-11","article-title":"The epidermal growth factor receptor (EGFR) in head and neck cancer: Its role and treatment implications","volume":"1","author":"Zimmermann","year":"2006","journal-title":"Radiat. Oncol"},{"key":"10.1074\/mcp.M111.011635_bib15","first-page":"135","article-title":"Clinical application of EGFR inhibitors in head and neck squamous cell cancer","volume":"139","author":"Astsaturov","year":"2008","journal-title":"Cancer Treat. Res"},{"key":"10.1074\/mcp.M111.011635_bib16","first-page":"2166","article-title":"Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis","volume":"6","author":"Huang","year":"2000","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/hed.21007","article-title":"Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma","volume":"31","author":"Mazumdar","year":"2009","journal-title":"Head Neck"},{"key":"10.1074\/mcp.M111.011635_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijrobp.2009.11.027","article-title":"Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma","volume":"77","author":"Gerster","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"10.1074\/mcp.M111.011635_bib19","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1158\/0008-5472.CAN-08-2881","article-title":"The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma","volume":"69","author":"Seiwert","year":"2009","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00216-007-1486-6","article-title":"Quantitative mass spectrometry in proteomics: A critical review","volume":"389","author":"Bantscheff","year":"2007","journal-title":"Anal. Bioanal. Chem"},{"key":"10.1074\/mcp.M111.011635_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nbt.1658","article-title":"Proteomics: A pragmatic perspective","volume":"28","author":"Mallick","year":"2010","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.M111.011635_bib22","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nbt1328","article-title":"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors","volume":"25","author":"Bantscheff","year":"2007","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.M111.011635_bib23","first-page":"1","article-title":"Proteomics-based strategies in kinase drug discovery","volume":"2007","author":"Bantscheff","year":"2007","journal-title":"Ernst Schering Found. Symp. Proc"},{"key":"10.1074\/mcp.M111.011635_bib24","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1021\/pr900080y","article-title":"A comparison of labeling and label-free mass spectrometry-based proteomics approaches","volume":"8","author":"Patel","year":"2009","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M111.011635_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/leu.2010.233","article-title":"Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells","volume":"25","author":"Kruse","year":"2011","journal-title":"Leukemia"},{"key":"10.1074\/mcp.M111.011635_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mc.2940130408","article-title":"Cellular immortality: A late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss","volume":"13","author":"Edington","year":"1995","journal-title":"Mol. Carcinog"},{"key":"10.1074\/mcp.M111.011635_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/002215540205000207","article-title":"Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection","volume":"50","author":"Eicheler","year":"2002","journal-title":"J. Histochem. Cytochem"},{"key":"10.1074\/mcp.M111.011635_bib28","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0277-5379(88)90335-5","article-title":"Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: Establishment, characterization and response to cytotoxic treatment","volume":"24","author":"Gioanni","year":"1988","journal-title":"Eur. J. Cancer Clin. Oncol"},{"key":"10.1074\/mcp.M111.011635_bib29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/gcc.20551","article-title":"High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx","volume":"47","author":"J\u00e4rvinen","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1074\/mcp.M111.011635_bib30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0964-1955(95)00027-F","article-title":"Development of a new invasion and metastasis model of human oral squamous cell carcinomas","volume":"31B","author":"Kawashiri","year":"1995","journal-title":"Eur. J. Cancer B Oral. Oncol"},{"key":"10.1074\/mcp.M111.011635_bib31","series-title":"Head and Neck Cancers","first-page":"185","article-title":"Human Cell Culture, Cancer Cell Lines","author":"Lansford","year":"1999"},{"key":"10.1074\/mcp.M111.011635_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hed.20478","article-title":"Head and neck squamous cell carcinoma cell lines: Established models and rationale for selection","volume":"29","author":"Lin","year":"2007","journal-title":"Head Neck"},{"key":"10.1074\/mcp.M111.011635_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0714.1989.tb01570.x","article-title":"Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas","volume":"18","author":"Momose","year":"1989","journal-title":"J. Oral Pathol. Med"},{"key":"10.1074\/mcp.M111.011635_bib34","first-page":"1121","article-title":"Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells","volume":"60","author":"O-charoenrat","year":"2000","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archotol.1994.01880310054010","article-title":"Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous carcinoma cell lines","volume":"120","author":"Pekkola-Heino","year":"1994","journal-title":"Arch. Otolaryngol. Head Neck Surg"},{"key":"10.1074\/mcp.M111.011635_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF01613295","article-title":"Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity","volume":"117","author":"Pekkola-Heino","year":"1991","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"10.1074\/mcp.M111.011635_bib37","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1002\/cncr.23934","article-title":"Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma","volume":"113","author":"Dos Reis","year":"2008","journal-title":"Cancer"},{"key":"10.1074\/mcp.M111.011635_bib38","first-page":"1657","article-title":"Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas","volume":"41","author":"Rheinwald","year":"1981","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.oraloncology.2006.09.001","article-title":"The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines","volume":"43","author":"White","year":"2007","journal-title":"Oral Oncol"},{"key":"10.1074\/mcp.M111.011635_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/03008209309032928","article-title":"A variant form of laminin is responsible for the neurite outgrowth-promoting activity in conditioned medium from a squamous carcinoma cell line","volume":"30","author":"Yoshida","year":"1993","journal-title":"Connect. Tissue Res"},{"key":"10.1074\/mcp.M111.011635_bib41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.radonc.2009.04.019","article-title":"Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro","volume":"92","author":"Zhang","year":"2009","journal-title":"Radiother. Oncol"},{"key":"10.1074\/mcp.M111.011635_bib42","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0140-6736(01)07110-0","article-title":"PTEN mutations and proteus syndrome","volume":"358","author":"Eng","year":"2001","journal-title":"Lancet"},{"key":"10.1074\/mcp.M111.011635_bib43","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1074\/mcp.M110.001073","article-title":"Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry","volume":"9","author":"Hauck","year":"2010","journal-title":"Mol. Cell Proteomics"},{"issue":"Suppl. 18","key":"10.1074\/mcp.M111.011635_bib44","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/bioinformatics\/18.suppl_1.S96","article-title":"Variance stabilization applied to microarray data calibration and to the quantification of differential expression","volume":"1","author":"Huber","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1074\/mcp.M111.011635_bib45","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1074\/mcp.M900628-MCP200","article-title":"Addressing accuracy and precision issues in iTRAQ quantitation","volume":"9","author":"Karp","year":"2010","journal-title":"Mol. Cell Proteomics"},{"key":"10.1074\/mcp.M111.011635_bib46","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat. Appl. Genet. Mol. Biol"},{"key":"10.1074\/mcp.M111.011635_bib47","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: Open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol"},{"key":"10.1074\/mcp.M111.011635_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B Methodol"},{"key":"10.1074\/mcp.M111.011635_bib49","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1186\/1471-2407-10-608","article-title":"High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I\u2013IIA) esophageal adenocarcinoma","volume":"10","author":"Rauser","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1074\/mcp.M111.011635_bib50","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1074\/mcp.M500301-MCP200","article-title":"Differential label-free quantitative proteomic analysis of Shewanella oneidensis cultured under aerobic and suboxic conditions by accurate mass and time tag approach","volume":"5","author":"Fang","year":"2006","journal-title":"Mol. Cell Proteomics"},{"key":"10.1074\/mcp.M111.011635_bib51","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1158\/1535-7163.MCT-07-0200","article-title":"A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells","volume":"6","author":"Wykosky","year":"2007","journal-title":"Mol. Cancer Ther"},{"key":"10.1074\/mcp.M111.011635_bib52","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1038\/sj.onc.1205758","article-title":"Activation of the EphA2 tyrosine kinase stimulates the MAP\/ERK kinase signaling cascade","volume":"21","author":"Pratt","year":"2002","journal-title":"Oncogene"},{"key":"10.1074\/mcp.M111.011635_bib53","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo","year":"2004","journal-title":"J. Med. Chem"},{"key":"10.1074\/mcp.M111.011635_bib54","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1586\/14737140.4.6.1113","article-title":"Targeting protein kinases in cancer therapy: A success?","volume":"4","author":"Pearson","year":"2004","journal-title":"Expert Rev. Anticancer Ther"},{"key":"10.1074\/mcp.M111.011635_bib55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/annonc\/mdl175","article-title":"Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer","volume":"18","author":"Cruz","year":"2007","journal-title":"Ann. Oncol"},{"key":"10.1074\/mcp.M111.011635_bib56","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1200\/JCO.2009.22.9054","article-title":"Personalized cancer therapy with selective kinase inhibitors: An emerging paradigm in medical oncology","volume":"27","author":"McDermott","year":"2009","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/mcp.M111.011635_bib57","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/437491a","article-title":"Pharmaceuticals: A new grammar for drug discovery","volume":"437","author":"Fishman","year":"2005","journal-title":"Nature"},{"key":"10.1074\/mcp.M111.011635_bib58","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/bjc.1996.525","article-title":"Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma","volume":"74","author":"Maurizi","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1074\/mcp.M111.011635_bib59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.1073096","article-title":"Cancer: Addiction to oncogenes: The Achilles heal of cancer","volume":"297","author":"Weinstein","year":"2002","journal-title":"Science"},{"key":"10.1074\/mcp.M111.011635_bib60","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0962-8924(99)01658-X","article-title":"The Aurora\/Ipl1p kinase family: Regulators of chromosome segregation and cytokinesis","volume":"9","author":"Bischoff","year":"1999","journal-title":"Trends Cell Biol"},{"key":"10.1074\/mcp.M111.011635_bib61","doi-asserted-by":"crossref","first-page":"12296","DOI":"10.1074\/jbc.273.20.12296","article-title":"RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis","volume":"273","author":"Inohara","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M111.011635_bib62","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1541-7786.MCR-05-0056","article-title":"EphA2 as a novel molecular marker and target in glioblastoma multiforme","volume":"3","author":"Wykosky","year":"2005","journal-title":"Mol. Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib63","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1517\/14728222.9.6.1179","article-title":"EphA2 as a target for ovarian cancer therapy","volume":"9","author":"Landen","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1074\/mcp.M111.011635_bib64","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/sj.onc.1207247","article-title":"EphA2: A determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma","volume":"23","author":"Duxbury","year":"2004","journal-title":"Oncogene"},{"key":"10.1074\/mcp.M111.011635_bib65","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1158\/1078-0432.CCR-09-0473","article-title":"Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer","volume":"15","author":"Brannan","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib66","first-page":"1079","article-title":"Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies","volume":"19","author":"Rivera","year":"2008","journal-title":"Oncol. Rep"},{"key":"10.1074\/mcp.M111.011635_bib67","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.oraloncology.2008.01.018","article-title":"Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: Correlation with the angiogenesis and clinical outcome","volume":"44","author":"Shao","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1074\/mcp.M111.011635_bib68","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1158\/1541-7786.MCR-08-0244","article-title":"The EphA2 receptor and ephrinA1 ligand in solid tumors: Function and therapeutic targeting","volume":"6","author":"Wykosky","year":"2008","journal-title":"Mol. Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib69","unstructured":"Gene Expression Atlas: ArrayExpress database: http:\/\/www.ebi.ac.uk\/gxa under accession number E-MTAB-62"},{"key":"10.1074\/mcp.M111.011635_bib70","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/leu.2009.50","article-title":"CYT387, a selective JAK1\/JAK2 inhibitor: In vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients","volume":"23","author":"Pardanani","year":"2009","journal-title":"Leukemia"},{"key":"10.1074\/mcp.M111.011635_bib71","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1158\/0008-5472.CAN-03-2420","article-title":"Lyn is a target gene for prostate cancer: Sequence-based inhibition induces regression of human tumor xenografts","volume":"64","author":"Goldenberg-Furmanov","year":"2004","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4615-5873-6_9","article-title":"Tyrosine kinases wee1 and mik1 as effectors of DNA replication checkpoint control","volume":"2","author":"Tourret","year":"1996","journal-title":"Prog. Cell Cycle Res"},{"key":"10.1074\/mcp.M111.011635_bib73","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2407-11-156","article-title":"WEE1 inhibition sensitizes osteosarcoma to radiotherapy","volume":"11","author":"PosthumaDeBoer","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1074\/mcp.M111.011635_bib74","first-page":"2011","article-title":"Adaptive radiation therapy for head and neck cancer-can an old goal evolve into a new standard?","author":"Schwartz","year":"2011","journal-title":"J. Oncol"},{"key":"10.1074\/mcp.M111.011635_bib75","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrclinonc.2009.129","article-title":"Src kinases as therapeutic targets for cancer","volume":"6","author":"Kim","year":"2009","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"10.1074\/mcp.M111.011635_bib76","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1158\/0008-5472.CAN-05-4620","article-title":"Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival","volume":"66","author":"Song","year":"2006","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib77","first-page":"7345","article-title":"A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo","volume":"63","author":"Christensen","year":"2003","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M111.011635_bib78","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","article-title":"Tissue microarrays for high-throughput molecular profiling of tumor specimens","volume":"4","author":"Kononen","year":"1998","journal-title":"Nat. Med"}],"container-title":["Molecular &amp; Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620305831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620305831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M111.011635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:17:58Z","timestamp":1761524278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620305831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":78,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1535947620305831"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m111.011635","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative Chemical Proteomics Reveals New Potential Drug Targets in Head and Neck Cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M111.011635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"M111.011635"}}